对因子适应性多臂多阶段 (FAST) 临床试验的设计考虑
Jonathan Beall1, Jordan Elm2, Matthew W Semler3
1Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA. bealljo@musc.edu.
Trials
|September 11, 2024
概括
工事自适应多臂多阶段 (FAST) 试验设计结合了MAMS和工事设计的优势. 仔细规划分析和时间对于优化FAST试验运行特征至关重要.
科学领域:
- 临床试验设计 临床试验设计
- 生物统计学 生物统计学
- 药学研究 药学研究
背景情况:
- 多臂,多阶段 (MAMS) 设计有助于在试验阶段中比较多种疗法.
- 工厂设计与MAMS相结合,比传统的固定设计提高了效率.
- 工厂式自适应式多臂多阶段 (FAST) 设计整合了工厂式和MAMS方法.
研究的目的:
- 为了探索FAST试验的设计选择.
- 评估分析类型,时间和效果大小对FAST试验运行特征的影响.
- 与MAMS和因数设计相比,评估FAST设计的潜在好处.
主要方法:
- 用模拟研究来分析FAST设计.
- 评估了分析类型,时间和效果大小对试验运行特征的影响.
- 分析方法根据多个结果的数据类型而有所不同.
主要成果:
- 快速设计为对MAMS和因数试验的潜在改进提供了一个框架.
- 设计实施决策显著影响试验运行特征.
- 模拟结果强调了分析时间和类型的重要性.
结论:
- 快速试验可能具有与MAMS和因数设计相似的优势.
- 在规划阶段对设计方面进行彻底的探索对于FAST试验至关重要.
- 选择的设计元素对FAST试验的成功和效率产生了重大影响.
相关概念视频
Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K
Factorial Design
13.0K
Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
13.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Randomized Experiments
6.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.8K
Hazard Ratio
96
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
96


